Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Down 29.5% in November

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) saw a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 31,100 shares, a drop of 29.5% from the November 15th total of 44,100 shares. Currently, 0.2% of the company’s shares are short sold. Based on an average daily volume of 72,000 shares, the days-to-cover ratio is presently 0.4 days.

Rapid Micro Biosystems Trading Down 1.9 %

RPID stock traded down $0.02 during midday trading on Friday, reaching $1.00. 20,566 shares of the company’s stock traded hands, compared to its average volume of 91,788. Rapid Micro Biosystems has a fifty-two week low of $0.58 and a fifty-two week high of $1.34. The business has a 50-day moving average price of $1.03 and a two-hundred day moving average price of $0.86.

Rapid Micro Biosystems (NASDAQ:RPID) last announced its quarterly earnings results on Friday, November 1st. The company reported ($0.26) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.01). Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. The business had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $6.30 million. During the same period last year, the company posted ($0.31) earnings per share. On average, analysts anticipate that Rapid Micro Biosystems will post -1.09 EPS for the current year.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.